⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for repaglinide

Every month we try and update this database with for repaglinide cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Pharmacokinetic Interaction Study Between Apatinib Mesylate and Repaglinide or Bupropion in Advanced Solid Tumor SubjectsNCT04457180
Advanced Solid ...
Apatinib Mesyla...
Repaglinide
Bupropion
18 Years - 70 YearsJiangsu HengRui Medicine Co., Ltd.
Open-Label, Multicenter, Two-Part, Phase 1 Study to Characterize Effects of a Moderate CYP3A Inhibitor on PK of Tazemetostat, Effects of Tazemetostat on PK of CYP2C8 and CYP2C19 Substrates, and Effect of Increased Gastric pH on PK of Tazemetostat in B-cell Lymphoma or Advanced Solid Tumor PatientsNCT03028103
Diffuse Large B...
Primary Mediast...
Mantle Cell Lym...
Advanced Solid ...
Marginal Zone L...
Tazemetostat
Fluconazole
Omeprazole
Repaglinide
18 Years - Ipsen
Open-Label, Multicenter, Two-Part, Phase 1 Study to Characterize Effects of a Moderate CYP3A Inhibitor on PK of Tazemetostat, Effects of Tazemetostat on PK of CYP2C8 and CYP2C19 Substrates, and Effect of Increased Gastric pH on PK of Tazemetostat in B-cell Lymphoma or Advanced Solid Tumor PatientsNCT03028103
Diffuse Large B...
Primary Mediast...
Mantle Cell Lym...
Advanced Solid ...
Marginal Zone L...
Tazemetostat
Fluconazole
Omeprazole
Repaglinide
18 Years - Ipsen
A Drug-Drug Interaction Study to Evaluate the Effect of Ripretinib on the Pharmacokinetics of a CYP2C8 Probe Substrate in Patients With Advanced GISTNCT04530981
GIST - Gastroin...
Ripretinib
Repaglinide
18 Years - Deciphera Pharmaceuticals LLC
A Drug-Drug Interaction Study to Evaluate the Effect of Ripretinib on the Pharmacokinetics of a CYP2C8 Probe Substrate in Patients With Advanced GISTNCT04530981
GIST - Gastroin...
Ripretinib
Repaglinide
18 Years - Deciphera Pharmaceuticals LLC
A Drug-Drug Interaction Study to Evaluate the Effect of Ripretinib on the Pharmacokinetics of a CYP2C8 Probe Substrate in Patients With Advanced GISTNCT04530981
GIST - Gastroin...
Ripretinib
Repaglinide
18 Years - Deciphera Pharmaceuticals LLC
A Pharmacokinetic Interaction Study Between Apatinib Mesylate and Repaglinide or Bupropion in Advanced Solid Tumor SubjectsNCT04457180
Advanced Solid ...
Apatinib Mesyla...
Repaglinide
Bupropion
18 Years - 70 YearsJiangsu HengRui Medicine Co., Ltd.
A Drug-Drug Interaction Study to Evaluate the Effect of Ripretinib on the Pharmacokinetics of a CYP2C8 Probe Substrate in Patients With Advanced GISTNCT04530981
GIST - Gastroin...
Ripretinib
Repaglinide
18 Years - Deciphera Pharmaceuticals LLC
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: